MAGELLAN® Autologous Platelet Separator

System Overview

Technology Leadership

Arteriocyte Medical Systems couples its expertise in autologous cellular therapies and Medtronic’s proven technology with the Magellan® Autologous Platelet Separator System. Our partner Medtronic has been an industrial leader in blood component therapies for more than a decade. Arteriocyte Medical Systems continues to build upon this platform for blood conservation and autologous platelet component therapies, as well take development to the next level with exciting new applications for enhancing surgical outcomes with the Magellan® system .

Harnessing the healing
power of platelets

Superior Performance

• Magellan® System provides consistent platelet concentration.
• Consistently reproducible results are independent of operator and patient variability.
• Closed system, start-to-finish, reduces operator error and minimizes contamination.

Built-In Efficiency

• Small, portable platelet separator-ideal for use in a variety of clinical settings.
• Variable input (whole blood) and output (PRP) allow clinicians to customize volume requirements to meet specific clinical needs.
• Requires a small amount of blood.

Cost Effective

• Magellan® System has the potential to replace more expensive technologies at a lower cost.
• Up to three cycles can be conducted with the same patient-eliminating the cost of additional separation disposables.
• Ease of use reduces training time and expenditure.

Ease of Use

• Intuitive user interface reduces training time and related expenditures.

Pioneering Technology

These photos were taken with a strobe to show the Magellan® System disposable in motion during separation

Platelet concentration can be customized depending on patient need